Israeli Pharmaceutical Giant Teva Gets FDA Approval for Leukemia Drug

Synribo treats a type of chronic myelogenous leukemia in patients whose cancer has progressed after treatment with at least two drugs from a class called tyrosine kinase inhibitors.

comments Print

The U.S. Food and Drug Administration on Friday said it has approved a new leukemia treatment from Teva Pharmaceutical Industries Ltd to be sold...